| Literature DB >> 27115024 |
Shoin Tei1, Hiroaki Mitsuhashi1, Shoichi Ishiura1.
Abstract
This data article tested whether polymorphisms within the dopamine D4 receptor (DRD4) gene promoter can lead to differences in the promoter activity. The variants, a 120-bp variable number tandem repeat (VNTR), -906 T/C, -809 G/A, -616G/C, and -521C/T, were introduced into the DRD4 promoter and the promoter activity was measured in a neural cell line using the luciferase assay. However, no differences were detected among the haplotypes investigated, and the in vitro data obtained from our protocol could not support the involvement of DRD4 promoter polymorphisms in heritable human traits.Entities:
Year: 2016 PMID: 27115024 PMCID: PMC4833125 DOI: 10.1016/j.dib.2016.03.084
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Fig. 1RT-PCR analysis of DRD4 gene expression. DRD4 expression in SH-SY5Y cells was detected using RT-PCR. The housekeeping gene GAPDH was amplified as an internal control.
Fig. 2Schematic representation of the DRD4 gene and the reporter construct with the locations of the polymorphisms studied. The DNA fragment cloned here corresponded to region −1576 to −1 relative to the translation start site, and was the longest among functional assays on mutated DRD4 promoter;−591 to −123 was cloned in Okuyama et al [2], −1389 to −1203 in D׳Souza et al. [3], −668 to −389 in Kreszturi et al. [4] and −1571 to −389 in Kreszturi et al. [5].The putative silencer (dark grey boxes, −1571 to −800 and −770 to −678) and enhancer (light grey box, −591 to −123) regions are indicated in the DRD4 gene promoter (white arrow) [1], [4]. The 120-bp VNTR is 1.2 kb upstream from the initial codon, and −521C/T is a C/T SNP at −521 in the promoter region (the description can be applied to the other SNPs). The promoter was cloned upstream of the firefly luciferase gene, so that luciferase expression was driven by the promoter. pGL3 promoter which contains SV40 promoter upstream luciferase gene was used as positive control.
The constructed haplotypes consisted of 120-bp VNTR and four SNPs of the DRD4 gene.
| Reporter construct | 120 bp VNTR | −906 C/T | −809 G/A | −616 G/C | −521 C/T |
|---|---|---|---|---|---|
| 1R-WT | 1 | T | G | G | C |
| 1R-521 | 1 | T | G | G | |
| 1R-616 | 1 | T | G | C | |
| 1R-809 | 1 | T | G | C | |
| 1R-906 | 1 | G | G | C | |
| 2R-WT | 2 | T | G | G | C |
| 2R-521 | 2 | T | G | G | |
| 2R-616 | 2 | T | G | C | |
| 2R-809 | 2 | T | G | C | |
| 2R-906 | 2 | G | G | C | |
| 1R-521-616 | 1 | T | G | ||
| 1R-521-809 | 1 | T | G | ||
| 1R-521-906 | 1 | G | G | ||
| 1R-616-809 | 1 | T | C | ||
| 1R-616-906 | 1 | G | C | ||
| 1R-809-906 | 1 | G | C | ||
| 1R-521-616-809 | 1 | T | |||
| 1R-521-616-906 | 1 | G | |||
| 1R-521-809-906 | 1 | G | |||
| 1R-616-809-906 | 1 | C | |||
| 1R-521-616-809-906 | 1 | ||||
| 2R-521-616 | 2 | T | G | ||
| 2R-521-809 | 2 | T | G | ||
| 2R-521-906 | 2 | G | G | ||
| 2R-616-809 | 2 | T | C | ||
| 2R-616-906 | 2 | G | C | ||
| 2R-809-906 | 2 | G | C | ||
| 2R-521-616-809 | 2 | T | |||
| 2R-521-616-906 | 2 | G | |||
| 2R-521-809-906 | 2 | G | |||
| 2R-616-809-906 | 2 | C | |||
| 2R-521-616-809-906 | 2 |
Fig. 3The effect of the polymorphisms on the DRD4 promoter activity. DRD4 promoter activity was measured as the luciferase activity in SH-SY5Y cells. The relative luciferase activity of pGL3-Basic was defined as 1 and pGL3 promoter was used as positive control. The assay failed to detect any significant differences between haplotypes. Data are expressed as means±SD (n=5) (Tukey–Kramer test, **p<0.01).
Fig. 4The effect of the combined polymorphisms on the DRD4 promoter activity. DRD4 promoter activity was measured as luciferase activity in SH-SY5Y cells. The relative luciferase activity of pGL3-Basic was defined as 1 and pGL3 promoter was used as positive control. The assay failed to detect any significant differences between haplotypes. Data are expressed as means±SD (n=4) (Tukey–Kramer test, **p<0.01).
Primer sequences and application.
| Application | Forward | Reverse |
|---|---|---|
| Amplification of DRD4 promoter | ACCActcgaGAGGCTGGGCTGGACTCGCCGTTT | AAGGaagcttGGCGCGCCCGGGCGG |
| ⁎The lower-case letters represent XhoI or HindIII restriction sites. | ||
| Nucleotide substitution −916 T>C | GAAGAGTCCATAGAA | GCAAAGCGCAGCAGAGA |
| Nucleotide substitution −809 G>A | CGAGCCGAACCT | CGGGACCGGACAG |
| Nucleotide substitution −616 G>C | GCGGGGGCTGAG | GCAGCCTCTGGT |
| Nucleotide substitution −521 T>C | GCGTGGAGGG | CCTCGTGCGC |
| ⁎The underlined letters correspond to each SNP | ||
| RT-PCR of | GCACCGCCTCCATCTTCAACC | CGGAACGTGGCCCAGTAGAGC |
| RT-PCR of | AAGGCTGAGAACGGGAAGCTTGTCATCAAT | TTCCCGTCTAGCTCAGGGATGACCTTGCCC |
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |